Clinical Trials Directory

Trials / Unknown

UnknownNCT04632693

Soft Tissue Augmentation Using CAF With Either SCTG and Vitamin C Versus SCTG Alone in Management of RT1 Gingival Recession

Soft Tissue Augmentation Using Coronally Advanced Flap With Either Subepithelial Connective Tissue and Vitamin C Versus Subepithelial Connective Tissue Graft Alone in Management of RT1 Gingival Recession

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
22 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Compare gingival thickness following CAF With SCTG and Vitamin C Versus SCTG Alone in Management of RT1 Gingival Recession.

Detailed description

Control group (coronally advanced flap and subepithelial connective tissue graft alone) Test group (coronally advanced flap and subepithelial connective tissue graft using microsurgical approach) Same procedure will be executed but with the addition of vitamin C injection. Intraepidermal injection (oral mesotherapy technique) of 1-1.5 ml (200-300 mg concentration) of L-ascorbic acid will be done. It will be locally introduced in relation to the keratinized gingival tissues with extension to the whole target region successively using special syringes (30 gauge). The needle will be introduced parallel to the gingival tissues with the bevel facing upwards. Vitamin C will then be delivered through the attached gingival tissues at the epithelium-connective tissue junction (equivalent to epidermal- dermal junction) till the tissues blanch. Vitamin C will be injected first time immediately postsurgical and then repeated once per week for 3 consecutive weeks for a total of 4 injections.

Conditions

Interventions

TypeNameDescription
PROCEDURECAF with SCTG and Vitamin C injectionInjection of vitamin C after CAF with SCTG aiming to increase gingival thickness in patients with RT1 gingival recession.
PROCEDURECAF with SCTG aloneCoronally advanced flap with subepithelial connective tissue graft.

Timeline

Start date
2020-09-01
Primary completion
2021-05-01
Completion
2021-06-01
First posted
2020-11-17
Last updated
2020-11-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04632693. Inclusion in this directory is not an endorsement.